Antisense compounds, compositions and methods are provided for modulating the expression of PTPN12. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding PTPN12. Methods of using these compounds for modulation of PTPN12 expression and for treatment of diseases associated with expression of PTPN12 are provided.

 
Web www.patentalert.com

< IL-1ra variants

< 6-11 Bicyclic ketolide derivatives

> Modulation of growth hormone receptor expression and insulin-like growth factor expression

> Antisense oligonucleotides for treating atopic diseases and neoplastic cell proliferation

~ 00228